These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 19251209)

  • 1. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia.
    Tan BH; Iturralde-Torres P; Medeiros-Domingo A; Nava S; Tester DJ; Valdivia CR; Tusié-Luna T; Ackerman MJ; Makielski JC
    Cardiovasc Res; 2007 Dec; 76(3):409-17. PubMed ID: 17897635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac sodium channelopathy from bench to bedside].
    Zhang YM; Zhou N
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
    [No Abstract]   [Full Text] [Related]  

  • 8. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
    Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
    Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
    Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
    Circulation; 2006 Nov; 114(19):2026-33. PubMed ID: 17075016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
    Amin AS; Boink GJ; Atrafi F; Spanjaart AM; Asghari-Roodsari A; Molenaar RJ; Ruijter JM; Wilde AA; Tan HL
    Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-Phenotype Correlation of
    Yamagata K; Horie M; Aiba T; Ogawa S; Aizawa Y; Ohe T; Yamagishi M; Makita N; Sakurada H; Tanaka T; Shimizu A; Hagiwara N; Kishi R; Nakano Y; Takagi M; Makiyama T; Ohno S; Fukuda K; Watanabe H; Morita H; Hayashi K; Kusano K; Kamakura S; Yasuda S; Ogawa H; Miyamoto Y; Kapplinger JD; Ackerman MJ; Shimizu W
    Circulation; 2017 Jun; 135(23):2255-2270. PubMed ID: 28341781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.
    Robyns T; Nuyens D; Vandenberk B; Kuiperi C; Corveleyn A; Breckpot J; Garweg C; Ector J; Willems R
    Ann Noninvasive Electrocardiol; 2018 Sep; 23(5):e12548. PubMed ID: 29709101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
    Hu D; Barajas-Martinez H; Nesterenko VV; Pfeiffer R; Guerchicoff A; Cordeiro JM; Curtis AB; Pollevick GD; Wu Y; Burashnikov E; Antzelevitch C
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):274-85. PubMed ID: 20025708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implications of genetic mutations in the sodium channel gene (SCN5A).
    Moric E; Herbert E; Trusz-Gluza M; Filipecki A; Mazurek U; Wilczok T
    Europace; 2003 Oct; 5(4):325-34. PubMed ID: 14753626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
    Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
    Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.